tiprankstipranks
Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ:ARWR
US Market
ARWR
Arrowhead Pharmaceuticals
RESEARCH TOOLSreports
Want to see ARWR full AI Analyst Report?

Arrowhead Pharmaceuticals (ARWR) Stock News & Sentiment

1,686 Followers
Arrowhead’s Inhaled ARO-RAGE Asthma Trial Enters Active Recruitment, Keeping a Key Pipeline Catalyst in Play
Premium
Company Announcements
Arrowhead’s Inhaled ARO-RAGE Asthma Trial Enters Active Recruitment, Keeping a Key Pipeline Catalyst in Play
2d ago
ARWR
Arrowhead Pharmaceuticals: Buy Rating Reaffirmed as ARO-INHBE Data Strengthen Outlook and $100 Price Target Maintained
Premium
Ratings
Arrowhead Pharmaceuticals: Buy Rating Reaffirmed as ARO-INHBE Data Strengthen Outlook and $100 Price Target Maintained
3d ago
ARWR
Arrowhead’s ARO-C3 Kidney Trial Reaches Completion, Setting Up the Next Catalyst for ARWR Investors
Premium
Company Announcements
Arrowhead’s ARO-C3 Kidney Trial Reaches Completion, Setting Up the Next Catalyst for ARWR Investors
8d ago
ARWR
Arrowhead’s ARO-CFB Kidney Trial Completion: What Investors Should Watch Next
Premium
Company Announcements
Arrowhead’s ARO-CFB Kidney Trial Completion: What Investors Should Watch Next
10d ago
ARWR
Arrowhead Pharmaceuticals’ Earnings Call: Launch, Losses, Bets
Premium
Company Announcements
Arrowhead Pharmaceuticals’ Earnings Call: Launch, Losses, Bets
21d ago
ARWR
Is ARWR a Buy, Before Earnings?
Premium
Pre-Earnings
Is ARWR a Buy, Before Earnings?
25d ago
ARWR
Arrowhead, Astera, Exxon, Intel, Halliburton Trending With Analysts
Premium
Weekend Updates
Arrowhead, Astera, Exxon, Intel, Halliburton Trending With Analysts
1M ago
HAL
XOM
More ARWR News >

ARWR News on the Web

Arrowhead’s Inhaled ARO-RAGE Asthma Trial Enters Active Recruitment, Keeping a Key Pipeline Catalyst in Play
TipRanks News
Bullish
Arrowhead Pharmaceuticals (ARWR) Gets a Buy from H.C. Wainwright
TipRanks News
Bullish
Arrowhead Pharmaceuticals: Buy Rating Reaffirmed as ARO-INHBE Data Strengthen Outlook and $100 Price Target Maintained
TipRanks News
Bullish
Arrowhead presents interim results from Phase 1/2a trial of ARO-INHBE
TipRanks News
Bullish
Arrowhead presents clinical cardiometabolic data at EAS Congress
TipRanks News
Bullish
Arrowhead’s ARO-C3 Kidney Trial Reaches Completion, Setting Up the Next Catalyst for ARWR Investors
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Black Diamond Therapeutics (BDTX) and Iovance Biotherapeutics (IOVA)
TipRanks News
Bullish
Analysts Conflicted on These Healthcare Names: Arrowhead Pharmaceuticals (ARWR), Syndax Pharmaceuticals (SNDX) and Fresenius Medical Care (FMS)
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
ARWR
Sector Average
Media Buzz
This Week5 articles
Weekly Average6 articles
News Sentiment
This Week99%
Sector Average79%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ARWR’s Media Buzz Sentiment?
5 articles about ARWR were published this week. In an average week, 6 articles are published.
    What is ARWR’s weekly average amount of articles?
    In an average week, 6 articles about ARWR are published.
      What is ARWR’s News Sentiment?
      99% of articles about ARWR were positive this week, compared to its sector average of 79%.
        Healthcare Stocks that are Trending in the News
        AKTXAkari Therapeutics
        IMMXImmix Biopharma
        SYSo-Young International
        ADOAnteoTech Ltd
        FSPKFFisher & Paykel Healthcare Corporation Limited
        Showing the stocks with the most bullish news sentiment over the past week